Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Yukasikado is developing a business on the axis of nutrition that supports the health of the body.
Cell fiber technology was developed as a basic technology for handling cells in the engineering field.
Targeting pathways that modify RNA to deliver novel cancer therapeutics
Varinos is a biotechnology company that offers new genomic testing and contract analysis services.
LUCA Science develops innovative treatments intended for mitochondrial and related diseases.
Braizon Therapeutics is a bio-venture firm originating from the University of Tokyo and Tokyo Medical and Dental University.
RIN Institute is a bio-venture firm dedicated to the research and development of antibody-based medicines and external diagnostic drugs.
Mentalhealth Technologies is a health care company.
ReasonWhy is a Healthcare×IT company based in Tokyo.
CYTLIMIC is a biotechnology company that develops immunotherapy products for the treatment of cancer, including a cancer peptide vaccine.
Purec is a biotech company developing culture technology for ultra-pure stem cells to enhance medical treatment efficacy.
VELDT Inc. is Japan's leading causal AI company which prvides Causal AI platform xCausa and Causal AI Assistant solutions.
NIL is a bio-tech company that develops innovative and functional ultrafine particle technology based on many years of research experience.
Fast Track Initiative has invested in 37 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Fast Track Initiative's top investment sectors include Health Care, Biotechnology, Medical, Biopharma, Pharmaceutical. The firm invests across 23 different industry categories.
Among tracked funding rounds, Storm Therapeutics received $30.0M in a Series B round. Fast Track Initiative's total known invested capital is $768.6M.
Fast Track Initiative's average investment size is $20.2M across its portfolio of 37 companies.
Recent Fast Track Initiative portfolio additions include Yukashikado, CellFiber, Storm Therapeutics, Varinos, LUCA Science. These companies were founded in 2020 or later.